两种罗库溴铵药效学模型在深神经肌肉阻滞中预测强直后计数的比较
这项前瞻性非随机观察性研究纳入30例择期腹部或神经外科手术成人患者,比较Saldien与De Haes两种罗库溴铵药代动力学模型结合药效学模型预测深神经肌肉阻滞期间强直后计数(PTC)的表现。结果显示两种模型对所有PTC分级预测性能良好,但对PTC>6存在中度高估,提示基于估计血浆浓度的药效学模型可用于指导罗库溴铵给药。
要点
- 两种药代动力学模型结合药效学模型预测PTC性能相当。
- 模型对所有PTC分级预测良好,但对PTC>6有中度高估。
- 基于估计血浆浓度的方法可辅助指导深神经肌肉阻滞时罗库溴铵用药。
核心结论
- 使用Saldien或De Haes模型估计的罗库溴铵血浆浓度结合药效学模型,在预测强直后计数时具有相同的模型性能。
研究设计与样本
- 前瞻性、非随机、观察性研究,纳入30例择期腹部或神经外科手术成人患者,罗库溴铵诱导后持续输注维持PTC 1-2,每3分钟测量一次。
主要发现
- 成功采用群体药效学分析表征罗库溴铵输注期间的强直后计数反应曲线。
- 两种模型对所有PTC分级均表现良好,但对PTC>6存在中度高估。
临床怎么用
- 在需要深神经肌肉阻滞的常规临床实践中,可使用任一模型估计的罗库溴铵血浆浓度结合药效学模型预测PTC,辅助指导罗库溴铵给药。
局限性
- 研究为非随机观察性设计,样本量30例,结论需进一步验证。
- 模型对PTC>6存在中度高估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Profound neuromuscular block (NMB) is important in surgeries where complete immobility is considered essential to improve tracheal intubation and surgical conditions. Rocuronium bromide is a commonly used NMB agent. This work describes a noninvasive approach for estimation of post-tetanic count (PTC) based on two pharmacokinetic (PK) models, the Saldien and the De Haes models. The aim was to investigate the rocuronium bromide PK-pharmacodynamic (PD) relationship in estimating the PTC effect during profound NMB. METHODS: In this prospective, non-randomised, observational study, an induction bolus of rocuronium bromide was administered followed by continuous infusion for maintenance of a PTC of 1-2. measured every 3 min. Measurements were analysed as discrete categorical data and by applying the nonlinear mixed-effect modelling approach. Performance of the selected models was evaluated through simulation model-based diagnostics, further assessing the precision of the parameter estimates and the performance of the models at the individual level. RESULTS: Data from 30 adult patients undergoing elective abdominal or neurosurgical procedures were included. Post-tetanic count response profiles during rocuronium bromide infusion were successfully characterised using the population PD analysis. The models showed a good performance for all PTC categories, albeit with a moderate over-prediction of PTC >6. CONCLUSIONS: Our findings indicate that using plasma concentrations of rocuronium bromide estimated with either of the two models, combined with a PD model, provides equal model performance when predicting PTC. These promising results may provide an important advance in guiding rocuronium bromide administration when profound NMB in routine clinical practice is desired.
引用
- Couto M, Vide S, Marco-Ariño N, et al. Comparison of two pharmacokinetic-pharmacodynamic models of rocuronium bromide during profound neuromuscular block: analysis of estimated and measured post-tetanic count effect. Br J Anaesth. 2022. PMID: 35120713. doi:10.1016/j.bja.2021.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。